McKinley Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-144,610
Closed -$3.66M 532
2016
Q4
$3.66M Sell
144,610
-115,803
-44% -$2.57M 0.14% 123
2016
Q3
$5.17M Buy
260,413
+102,459
+65% +$1.79M 0.19% 128
2016
Q2
$2.25M Sell
157,954
-41
-0% -$627 0.11% 179
2016
Q1
$2.45M Sell
157,995
-123
-0.1% -$1.76K 0.12% 162
2015
Q4
$2.73M Buy
158,118
+61,550
+64% +$891K 0.13% 162
2015
Q3
$1.18M Buy
+96,568
New +$1.24M 0.06% 209

Other funds holding LMAT

McKinley Capital Management's LMAT Position: Q1 2017 in Review

McKinley Capital Management sold out of LeMaitre Vascular (LMAT) in Q1 2017, closing a stake of 144,610 shares — an estimated $3.66M sold.

McKinley Capital Management first reported a position in LMAT in Q3 2015 and held it in 6 quarters. The position peaked at $5.17M in Q3 2016. 114 funds tracked by Wall St. Rank hold LMAT as of Q1 2017.

  • McKinley Capital Management reported no remaining LeMaitre Vascular position as of Q1 2017 after selling out during the quarter.
  • McKinley Capital Management sold 144,610 LeMaitre Vascular shares in Q1 2017, an estimated $3.66M.
  • McKinley Capital Management first reported a position in LeMaitre Vascular in Q3 2015 and held it in 6 quarters.
  • McKinley Capital Management's LeMaitre Vascular position peaked at $5.17M in Q3 2016.
  • 114 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2017.

Based on McKinley Capital Management's 13F filing for Q1 2017, filed 10 May 2017.